Related Experiment Videos
In vivo induced antigen technology (IVIAT)
Sean M Rollins1, Amanda Peppercorn, Long Hang
1Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Cellular Microbiology
|December 25, 2004
Summary
In vivo induced antigen technology (IVIAT) identifies key pathogen antigens expressed during human infections. These antigens are crucial for understanding disease mechanisms and developing new vaccines or diagnostics.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Identifying pathogen-expressed antigens during infection is critical for understanding host-pathogen interactions.
- Existing methods for identifying expressed genes may not fully capture antigens relevant during human infection.
Purpose of the Study:
- To introduce and describe In vivo Induced Antigen Technology (IVIAT) as a method for identifying immunogenic antigens expressed during human infection.
- To highlight the complementary nature of IVIAT to other gene identification techniques.
Main Methods:
- Utilizes the host's immune response during natural infection to identify pathogen antigens.
- Focuses on antigens that are specifically expressed and recognized by the host immune system in vivo.
Main Results:
- IVIAT successfully identifies pathogen antigens that are immunogenic and expressed during human infection.
- The identified antigens and gene pathways offer insights into virulence and pathogenesis.
Conclusions:
- IVIAT is a valuable tool for discovering novel vaccine candidates and diagnostic targets.
- Antigens identified via IVIAT can inform the development of therapeutics and vaccines for infectious diseases.